• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型钌环戊二烯基-肽缀合物复合物抗人 FGFR(+)乳腺癌。

Novel "ruthenium cyclopentadienyl"-peptide conjugate complexes against human FGFR(+) breast cancer.

机构信息

Centro de Química Estrutural, Faculdade de Ciências, Universidade de Lisboa, Campo Grande, 1749-016 Lisboa, Portugal.

出版信息

Dalton Trans. 2020 May 14;49(18):5974-5987. doi: 10.1039/d0dt00955e. Epub 2020 Apr 21.

DOI:10.1039/d0dt00955e
PMID:32314752
Abstract

In this work we explored the possibility of improving the selectivity of a cytotoxic Ru complex [RuCp(PPh)(2,2'-bipy)][CFSO] (where Cp = η-cyclopentadienyl) TM34 towards FGFR(+) breast cancer cells. Molecular dynamics (MD) simulations of TM34 in a phosphatidylcholine membrane model pinpointed the cyclopentadienyl group as a favorable derivatization position for the peptide conjugation approach. Three new Ru(ii) complexes presenting a functionalized η-cyclopentadienyl were synthesized, namely [Ru(η-CHCOOH)(2,2'-bipy)(PPh)][CFSO] (TM281) and its precursors, [Ru(η-CHCOOCHCH)(η-2,2'-bipy)(PPh)][CFSO] (3) and [Ru(η-CHCOOCHCH)(PPh)Cl] (2). Complex TM281 was prepared by the hydrolysis of the ethyl ester group appended to the η-cyclopentadienyl ligand of complex 3 with KCO in water/acetonitrile, followed by mild protonation using an ion exchange resin. The newly synthesized complexes were fully characterized by NMR, FTIR and UV-vis spectroscopic techniques. Also, electrochemical studies were carried out by means of cyclic voltammetry in order to evaluate the stability of the compounds. Single crystal X-ray diffraction studies were carried out for compounds 3 and TM281 which crystallized in the monoclinic system, space group P21/n. The unprecedented synthesis and characterization of three half-sandwich ruthenium(ii)-cyclopentadienyl peptide conjugates and their preliminary biological evaluation against human FGFR(+) and FGFR(-) breast cancer cells are also reported.

摘要

在这项工作中,我们探索了提高细胞毒性 Ru 配合物[RuCp(PPh)(2,2'-bipy)][CFSO](其中 Cp=η-环戊二烯基)TM34 对 FGFR(+)乳腺癌细胞选择性的可能性。在磷脂膜模型中对 TM34 的分子动力学(MD)模拟指出,环戊二烯基是肽键合方法的有利衍生化位置。合成了三个呈现官能化η-环戊二烯基的新 Ru(ii)配合物,即[Ru(η-CHCOOH)(2,2'-bipy)(PPh)]CFSO及其前体[Ru(η-CHCOOCHCH)(η-2,2'-bipy)(PPh)]CFSO和Ru(η-CHCOOCHCH)(PPh)Cl。通过 KCO 在水/乙腈中的水解,将 3 中η-环戊二烯基配体上的乙酯基团水解,然后用离子交换树脂温和质子化,制备配合物 TM281。新合成的配合物通过 NMR、FTIR 和 UV-vis 光谱技术进行了充分的表征。还通过循环伏安法进行了电化学研究,以评估化合物的稳定性。化合物 3 和 TM281 进行了单晶 X 射线衍射研究,它们结晶于单斜晶系,空间群 P21/n。还报道了三种半夹心钌(ii)-环戊二烯基肽缀合物的前所未有的合成和表征及其对人 FGFR(+)和 FGFR(-)乳腺癌细胞的初步生物学评价。

相似文献

1
Novel "ruthenium cyclopentadienyl"-peptide conjugate complexes against human FGFR(+) breast cancer.新型钌环戊二烯基-肽缀合物复合物抗人 FGFR(+)乳腺癌。
Dalton Trans. 2020 May 14;49(18):5974-5987. doi: 10.1039/d0dt00955e. Epub 2020 Apr 21.
2
Synthesis and biological assessment of a ruthenium(II) cyclopentadienyl complex in breast cancer cells and on the development of zebrafish embryos.钌(II)茂环戊二烯配合物在乳腺癌细胞中的合成及生物学评价及对斑马鱼胚胎发育的影响。
Eur J Med Chem. 2020 Feb 15;188:112030. doi: 10.1016/j.ejmech.2019.112030. Epub 2020 Jan 3.
3
Synthesis, X-ray structure, physicochemical properties and anticancer activity of mer and fac Ru(iii) triphenylphosphine complexes with a benzothiazole derivative as a co-ligand.标题:作为共配体的苯并噻唑衍生物的铱(III)和 fac Ru(III)三苯基膦配合物的合成、X 射线结构、物理化学性质和抗癌活性。
Dalton Trans. 2019 Jul 16;48(28):10689-10702. doi: 10.1039/c9dt01803d.
4
Dual FGFR-targeting and pH-activatable ruthenium-peptide conjugates for targeted therapy of breast cancer.双重 FGFR 靶向和 pH 激活型钌-肽偶联物用于乳腺癌的靶向治疗。
Dalton Trans. 2024 May 7;53(18):7682-7693. doi: 10.1039/d4dt00497c.
5
Half-Sandwich Iridium(III) and Ruthenium(II) Complexes Containing P^P-Chelating Ligands: A New Class of Potent Anticancer Agents with Unusual Redox Features.含P^P螯合配体的半夹心铱(III)和钌(II)配合物:一类具有异常氧化还原特性的新型强效抗癌剂。
Inorg Chem. 2018 Feb 19;57(4):1705-1716. doi: 10.1021/acs.inorgchem.7b01959. Epub 2018 Feb 5.
6
Improving Cytotoxicity against Breast Cancer Cells by Using Mixed-Ligand Ruthenium(II) Complexes of 2,2'-Bipyridine, Amino Acid, and Nitric Oxide Derivatives as Potential Anticancer Agents.采用 2,2'-联吡啶、氨基酸和一氧化氮衍生物的混合配体钌(II)配合物作为潜在抗癌药物提高乳腺癌细胞的细胞毒性。
Anticancer Agents Med Chem. 2021;21(12):1602-1611. doi: 10.2174/0929867327666201020155105.
7
On the Cytotoxicity of Chiral Ruthenium Complexes Containing Sulfur Amino Acids against Breast Tumor Cells (MDA-231 and MCF-7).含硫氨基酸手性钌配合物对乳腺癌细胞(MDA-231 和 MCF-7)的细胞毒性研究。
Anticancer Agents Med Chem. 2021;21(9):1172-1182. doi: 10.2174/1871520620666200824114816.
8
Ru( p-cymene) Compounds as Effective and Selective Anticancer Candidates with No Toxicity in Vivo.钌(对伞花烃)化合物是有效的、选择性的抗癌候选物,在体内无毒性。
Inorg Chem. 2018 Nov 5;57(21):13150-13166. doi: 10.1021/acs.inorgchem.8b01270. Epub 2018 Oct 19.
9
Novel family of [RuCp(N,N)(P)] compounds with simultaneous anticancer and antibacterial activity: Biological evaluation and solution chemistry studies.新型[RuCp(N,N)(P)]配合物家族兼具抗癌和抗菌活性:生物学评价和溶液化学研究。
Eur J Med Chem. 2023 Dec 15;262:115922. doi: 10.1016/j.ejmech.2023.115922. Epub 2023 Oct 31.
10
Cytotoxicity of Ru(II) piano-stool complexes with chloroquine and chelating ligands against breast and lung tumor cells: Interactions with DNA and BSA.含氯喹和螯合配体的钌(II)钢琴凳配合物对乳腺和肺癌细胞的细胞毒性:与DNA和牛血清白蛋白的相互作用
J Inorg Biochem. 2015 Dec;153:150-161. doi: 10.1016/j.jinorgbio.2015.07.016. Epub 2015 Jul 23.

引用本文的文献

1
Exploiting Co(III)-Cyclopentadienyl Complexes To Develop Anticancer Agents.利用 Co(III)-环戊二烯基配合物开发抗癌剂。
Inorg Chem. 2024 Apr 1;63(13):5783-5804. doi: 10.1021/acs.inorgchem.3c03696. Epub 2024 Mar 19.
2
Fighting Multidrug Resistance with Ruthenium-Cyclopentadienyl Compounds: Unveiling the Mechanism of P-gp Inhibition.用钌-环戊二烯化合物对抗多药耐药性:揭示 P-糖蛋白抑制的机制。
J Med Chem. 2023 Oct 26;66(20):14080-14094. doi: 10.1021/acs.jmedchem.3c01120. Epub 2023 Aug 24.
3
Cyclic Ruthenium-Peptide Conjugates as Integrin-Targeting Phototherapeutic Prodrugs for the Treatment of Brain Tumors.
环状钌-肽缀合物作为整合素靶向光治疗前药治疗脑肿瘤。
J Am Chem Soc. 2023 Jul 12;145(27):14963-14980. doi: 10.1021/jacs.3c04855. Epub 2023 Jun 28.
4
Ultrasonication Improves Solid Phase Synthesis of Peptides Specific for Fibroblast Growth Factor Receptor and for the Protein-Protein Interface RANK-TRAF6.超声处理改善了针对成纤维细胞生长因子受体和蛋白质-蛋白质界面 RANK-TRAF6 的肽的固相合成。
Molecules. 2021 Dec 3;26(23):7349. doi: 10.3390/molecules26237349.
5
Emerging Molecular Receptors for the Specific-Target Delivery of Ruthenium and Gold Complexes into Cancer Cells.新兴的分子受体可将钌和金配合物特异性靶向递送至癌细胞。
Molecules. 2021 May 25;26(11):3153. doi: 10.3390/molecules26113153.